Neurotrope
$1.119876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.11
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
$0.00 (0.00%) Today
-$0.01 (-0.89%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Neurotrope and other stocks, options, ETFs, and crypto commission-free!
About NTRP
Neurotrope, Inc. Common Stock, also called Neurotrope, is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. Read More The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. The listed name for NTRP is Neurotrope, Inc. Common Stock.
Employees
7
Headquarters
New York, New York
Founded
2011
Market Cap
26.63M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
86.10K
High Today
$1.13
Low Today
$1.09
Open Price
$1.13
Volume
34.29K
52 Week High
$3.85
52 Week Low
$0.63